{"name":"Vaneltix Pharma, Inc.","slug":"vaneltix-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPSGtiX2hPZWszV2stV2RIck1ELVM5QXNKOVFuSURndTNGX2c4UXBiYTRLUkJGcGM1RmNKS3p0YV9aUVJoSTVYcFlBa2ZMbVZVMHR4cFRGX0xESEQ3dUZlRHAxdnNMa2RXUHR0QmVlQmRLWHJPbG5NQ0twejlkT1BvV2VDaDZRU3RlZVRuS0hGMGVTSFNRaE5hbHE1cDVIZVph?oc=5","date":"2026-04-02","type":"pipeline","source":"openPR.com","summary":"Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum - openPR.com","headline":"Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPbTQ4dFNtN3ZWMHZHY1NwMmgzbVZvVzF0VElQNWVWWXVHQ1BjTXIxTmQ4VWY4RGdfVlFVYkU0LVBPbHZJQThMQmRHRGFYc19yYXZOeFJVSjh2UFNoR2hfT0tHZmZYdmdpVDJlOWtnQklZSERqdWxidWtvVjJCLWQyMVladEh4b0hsZ0lXZGRkWXFsc1FLU1hjWkdDdmx3WmNSQ0FfT1FGcmIxejI3Rnk3LWpCbm8yNS0xQmUtVFRsajhtTHdrWkZ6S3gwNTNxd1cxTkE3RWZnS2t6V3FLY2FUN2JQbGRrVWlMY1kzRkdRcUVVMms3WUhPQnhCbkwzeWxsRnFva0oyVEVjdUx6ZTAycFBQakh0dXVSRENRb2hfTjBoNEtUOTZGdGtNem5nemJBaEQ0elRhT245eG9H?oc=5","date":"2026-01-28","type":"trial","source":"GlobeNewswire","summary":"Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire","headline":"Chronic and Acute Pain Clinical Trial Pipeline Analysis:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxOUmQybk9TX2VZZTFLQVZuek1GNl9ZdUU2eFlSZTdVTWpqZEtLU3M2MnRVLURYT0VfWVFBMk95YTZEOHF0ZHhDZmFIcU0yWHBQUWY3TTQybWFVWmUyMkNBdlNGZ3l0TzhOSUJwZklSd0VONXFLd3RTSER4dDV5T1lkeUNrYnM4NTZzb1ZzVUFualNPV25vSXRIaXU4U2l4YjVkQUlQeE5MeWtpd3FqaHk4TVJwVWYyRS0yb0piNU9vZ2ZFUG1zdTJCWEdYbG1nQW1PNW9CWF9fWkEyY1Nwek9IenlzcERnTk96SzNxOWdvSDVGeUFXOXdZRFRrcndESU01SkNPMVN3X1pmQnQ5V1A1WllCaUhrRzJLSHVTdTY0cF80QQ?oc=5","date":"2025-09-24","type":"trial","source":"prnewswire.com","summary":"Moderate-to-Severe Acute Pain Market Anticipates Impressive Growth Trajectory at a CAGR of 14% During the Study Period (2020-2034) | DelveInsight - prnewswire.com","headline":"Moderate-to-Severe Acute Pain Market Anticipates Impressive Growth Trajectory at a CAGR of 14% During the Study Period (","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPNXpFMnZDTlh1Z21ETmN2dVVCTU80R09OcVNXQlpCYjFiVEpJbkNTT2V1VGUwWEZ3WjZzQVZNTVQxRmxsSEowNGlDaXFnd3NCX3JPcWZSRm5rU0hqM2tfVV9tRWdLa2lpendpZ3ZFeXdFTjNSVTdyYXN5eV9kMjV0VGtwM1JXU1laU21aZ3FyNVc?oc=5","date":"2025-08-04","type":"trial","source":"Yahoo Finance","summary":"Interstitial Cystitis Market to Grow Rapidly at a CAGR of 4% During the Study Period (2020-2034) | DelveInsight - Yahoo Finance","headline":"Interstitial Cystitis Market to Grow Rapidly at a CAGR of 4% During the Study Period (2020-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNYVRISlBMdHVUZ2MybDZHMEg4Rm50R1o4NG9XV3pJMGVPM0s2M3djdGRVaUVjTjhDa0QwOVp6UFBGUW0ybk9yaFl3clNyMnFOTXRYeW5DWlNkRWc0a3hVZ1JHUEp2cTdoUVF5VFVjMm1ldThHNEQ3WTV6dWdZNUt0OGlNNkJyclcxMTZhdTFZcHU?oc=5","date":"2023-06-21","type":"trial","source":"Yahoo Finance","summary":"Hyloris announces enrolment of first patient in a 4-arm clinical trial of Alenura(TM) - Yahoo Finance","headline":"Hyloris announces enrolment of first patient in a 4-arm clinical trial of Alenura(TM)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}